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1. INTRODUCTION {#ajmgb32603-sec-0002}
===============

*TMC1* mutations have recently been found to be one of the major causes of profound recessive deafness worldwide (Ayesha et al., [2016](#ajmgb32603-bib-0001){ref-type="ref"}). In humans, most *TMC1* mutations are recessive mutations associated with congenital non‐syndromic severe to profound deafness DFNB7/11, whereas dominant alleles of *TMC1* were reportedly associated with progressive loss of hearing DFNA36 (Kitajiri et al., [2007](#ajmgb32603-bib-0007){ref-type="ref"}). Until now, there were 84 definite pathogenic sites of *TMC1* reported in HGMD (<http://www.hgmd.cf.ac.uk/ac/index.php>); the pathogenicity of most of them was determined by a consanguineous marriage pedigree study, which showed a sporadic phenomenon. In this study, we discovered that a single site of *TMC1* (c.2050G\>C) from sporadic families in one region had a high incidence; single nucleotide polymorphisms (SNPs) were used to identify its founder effect.

The *TMC1* gene has 24 exons and spans 314,551 base pairs on chromosome 9q21.13. The protein, which functions as an ion channel or transporter to mediate K+ homeostasis for the normal function of cochlear hair cells, consists of 760 amino acids containing six transmembrane (TM) domains (Xue et al., [2013](#ajmgb32603-bib-0014){ref-type="ref"}). *TMC1* c.2050G\>C (p.D684H) is a missense variant in exon21. We used TMHMM2.0 to predict the structure of the *TMC1* protein, including its six TMs with cytoplasmic N‐ and C‐termini. The results indicated that *TMC1* c.2050G\>C (p.D684H) occurs in the extracellular region between TM5 and TM6, and that this mutation may affect ion channel function in hair cells.

2. MATERIALS AND METHODS {#ajmgb32603-sec-0003}
========================

2.1. Materials {#ajmgb32603-sec-0004}
--------------

### 2.1.1. Family recruitment and clinical evaluations {#ajmgb32603-sec-0005}

Three families were enrolled in this study. Deafness gene detection was performed over different periods in each family. The proband of the first family (XJA) was a student at the Xiamen Special Education School in Fujian province, whose common deafness gene detection (*GJB2*, *SLC26A4*, and *mtDNA 12SrRNA*) was negative. The other two probands (M126, M372) were outpatients at the Chinese PLA General Hospital. The three families were all from the same region of China: Southern Fujian. All probands had congenital severe to profound sensorineural hearing loss. Their standard audiometric evaluations and pedigrees are shown. (Figure [1](#ajmgb32603-fig-0001){ref-type="fig"}).

![Pedigrees of the three families and pure tone audiometric evaluations. \[Color figure can be viewed at <http://wileyonlinelibrary.com>\]](AJMG-177-301-g001){#ajmgb32603-fig-0001}

### 2.1.2. Xiamen special education school {#ajmgb32603-sec-0006}

In total, 110 of 155 unrelated patients with hearing impairment (152 students, 3 teachers) from Xiamen Special Education School in Fujian province were not found to have a definite etiology in three common deafness genes by Sanger sequencing of all exons of *GJB2*, *SLC26A4*, and *mtDNA 12SrRNA*. The patients were then screened for the *TMC1* gene (Yi et al., [2015](#ajmgb32603-bib-0016){ref-type="ref"}). In addition, 100 individuals with normal hearing from the Xiamen area were also screened for the *TMC1* gene.

2.2. Ethics statement and DNA samples {#ajmgb32603-sec-0007}
-------------------------------------

The protocol for this investigation was performed with the approval of the Ethics Committee of Chinese PLA General Hospital. All subjects or their guardians signed informed consent forms prior to blood sampling. Questionnaires included basic information such as name, age, address, family history, health records of the mother during pregnancy, and a clinical history of the patient such as infections and the use of aminoglycoside antibiotics. Physical examination, standard audiometric evaluations, and a computed tomography (CT) scan of the temporal bone of the probands were performed (Yi et al., [2015](#ajmgb32603-bib-0016){ref-type="ref"}). DNA was extracted from peripheral blood leukocytes using a commercially available DNA extraction kit (Watson Biotechnologies Inc., Shanghai, China).

2.3. Methods {#ajmgb32603-sec-0008}
------------

### 2.3.1. Targeted next‐generation sequencing {#ajmgb32603-sec-0009}

The next‐generation sequencing panel of MyGenostics was used for the three families (Ying et al., [2015](#ajmgb32603-bib-0017){ref-type="ref"}). This panel was designed with biotinylated oligo‐probes to capture all exons, splice sites, and immediate flanking intron sequences of 109 deafness genes (Table S1, Supplementary Information), including all known genes for non‐syndromic hearing loss and some relatively common genes for syndromic hearing loss (at the time when the panel was designed). Captured DNA fragments were sequenced on Illumina HiSeq2000 Analyzers. Data analysis and bioinformatics processing were performed following standard Illumina procedures. Reads were aligned to NCBI37/hg19 assembly using the BWA Multi‐Vision software package. SNVs were detected and genotyped with the GATK UnifiedGenotyper in single‐sample mode. Indels were identified using the GATK Indel Genotyper. Potentially pathogenic variants were defined as nonsense, missense, splice‐site, and indel variants that have allele frequencies under 0.01 (determined by databases including NCBI dbSNP, NHLBI ESP, and 1000 Genomes).

### 2.3.2. *TMC1* sequencing {#ajmgb32603-sec-0010}

All coding exons flanking 16--407 base pairs of the *TMC1* gene were sequenced in patients from Xiamen Special Education School and the control group. The primers used for amplification and sequencing are listed in Supplementary Table S2. PCRs were set up in a reaction volume of 25 μl, containing 50 ng of genomic DNA, 200 nM of each primer, 200 μm of each dNTP, and 1.25 units of DNA polymerase (TAKARA) and 1X buffer. After initial denaturation at 96°C for 5 min, 30 thermal cycles of 96°C for 20 s, 60°C for 30 s, and 72°C for 1 min were carried out, followed by incubation at 72°C with a 5‐min hold (Veriti 96‐Well Thermal Cycler, Applied Biosystems, Foster City, CA). Sequencing was performed with an ABI 3730 DNA sequencer (ABI, Foster City, CA). Results were analyzed with Sequence Mutation Detection software (CapitalBio, Beijing, China) using Human Genome GRCh38.p7 Primary Assembly as a reference.

### 2.3.3. SNPs and MassARRAY SNP genotyping {#ajmgb32603-sec-0011}

The SNPs used in the study were identified based on the NCBI database. SNPs for haplotypes were chosen as follows: (i) CHB (Han Chinese in Beijing, China) heterozygosity in the 1000 Genomes database; (ii) MAF (minimum allele frequency) of CHB of 0.3--0.7; and (iii) upstream, downstream, and internal SNPs of *TMC1* (Figure [2](#ajmgb32603-fig-0002){ref-type="fig"}). Analysis of the identified SNPs was performed using the MassARRAY SNP genotyping system (Sequenom, San Diego, CA). Genotyping assays (primers for PCR amplification and extension) were automatically designed by the Sequenom MassARRAY Assay Design 4.0 software (Supplementary Table S3). The steps of the PCR cycling program, SAP (shrimp alkaline phosphatase) cleanup procedure, primer extension, extended reaction resin cleanup, and genotyping were performed as per the protocol (Stacey, Liuda & Diana, [2009](#ajmgb32603-bib-0009){ref-type="ref"}).

![Single nucleotide polymorphisms of *TMC1* for haplotypes. \[Color figure can be viewed at <http://wileyonlinelibrary.com>\]](AJMG-177-301-g002){#ajmgb32603-fig-0002}

3. RESULTS {#ajmgb32603-sec-0012}
==========

3.1. NGS of families {#ajmgb32603-sec-0013}
--------------------

Three families were tested by targeted next‐generation sequencing (NGS) of the deafness gene panel. The coverage of targeted regions exceeded 99.0%, and the average depth was 387.4‐fold. Details of the bioinformatics analysis followed American College of Medical Genetics and Genomics standards and guidelines.

Candidate variants are summarized in Supplementary Table S4. Consistent with the recessive inheritance of the families, bi‐allelic mutations were identified in these probands. Ruling out the mutations that result in homozygous or compound heterozygotes in the normal hearing database (in‐house NGS database of our own lab), a homozygous *TMC1* c.2050G\>C was found through NGS in two deaf children in a XJA family with two heterozygous normal hearing parents.

3.2. Xiamen special education school {#ajmgb32603-sec-0014}
------------------------------------

One‐hundred fifty‐five unrelated patients with hearing impairment (152 students and 3 teachers) from Xiamen Special Education School in Fujian province were tested for three common deafness genes (*GJB2*, *SLC26A4*, and *mtDNA 12SrRNA*) of China. There were 20 patients (12.9%) confirmed to have *GJB2* deafness‐causing mutations, 18 (11.61%) confirmed to be carrying two *SLC26A4* pathogenic mutations, and 6 (3.87%) who carried a *mtDNA 12SrRNA* mutation. Except for the proband of the XJA family, 110 unrelated patients without positive genetic testing results from Xiamen Special Education School in Fujian province and an additional 100 negative samples from Xiamen with normal hearing were screened for the *TMC1* gene. Four patients were compound heterozygotes for *TMC1* mutations (Table [1](#ajmgb32603-tbl-0001){ref-type="table-wrap"}), including c.2050G\>C/c.804G\>A, c.2050G\>C/c.1127T\>C, c.2050G\>C/c.1165C\>T, and c.2050G\>C/c.1396_1398delAAC combinations. Only the parents of XT087 sent their blood samples for this study. The subject\'s father was heterozygous for the *TMC1* c.2050G\>C mutation, and the subject\'s mother was heterozygous for the *TMC1* c.1396_1398delAAC mutation. The other three compound heterozygotes of *TMC1* mutations were not verified due to the lack of parental DNA. These mutations were not detected in the 100 normal samples.

###### 

Compound heterozygotes of *TMC1* in Xiamen Special Education School

  Number   Mutation (cDNA)     Amino acid changes   Type of sequence variation   Exon   Category            Reference
  -------- ------------------- -------------------- ---------------------------- ------ ------------------- ---------------------------------------------------------------
  XT078    c.2050G\>C          p.D684H              Missense                     21     Pathogenic          Tahir et al. ([2015](#ajmgb32603-bib-0010){ref-type="ref"})
           c.804G\>A           p.W268X              Stop gain                    13     Novel               This study
  XT090    c.2050G\>C          p.D684H              Missense                     21     Pathogenic          Tahir et al. ([2015](#ajmgb32603-bib-0010){ref-type="ref"})
           c.1127T\>C          p.L376P              SNV                          15     Novel               This study
  XT161    c.2050G\>C          p.D684H              Missense                     21     Pathogenic          Tahir et al. ([2015](#ajmgb32603-bib-0010){ref-type="ref"})
           c\. 1165C\>T        p.R389X              Stop gain                    15     Pathogenic          Meyer et al. ([2005](#ajmgb32603-bib-0008){ref-type="ref"})
  XT087    c.2050G\>C          p.D684H              Missense                     21     Pathogenic          Tahir et al. ([2015](#ajmgb32603-bib-0010){ref-type="ref"})
           c.1396_1398delAAC   p.466del             Deletion                     16     Likely pathogenic   Fangzhu et al. ([2014](#ajmgb32603-bib-0003){ref-type="ref"})

SNV, single nucleotide variation.

© 2017 Wiley Periodicals, Inc.

We found three types of *TMC1* polymorphisms (c.45C\>T, c.1713C\>T, c.2208+49C\>T) and two heterozygotes of novel variants (c.1764‐4C\>A, c.2073G\>A\[p.K691K\]) in this group. In total, the percentage of *TMC1* mutations that account for the genetic etiology in Xiamen Special Education School was 3.2% (5/155), and the allele frequency of *TMC1* was 3.2% (10/310). The allele frequency of *TMC1* c.2050G\>C was 1.9% (6/310).

3.3. Mutation analysis {#ajmgb32603-sec-0015}
----------------------

There were four novel variants not reported before. We predicted their pathogenicity with software.

### 3.3.1. c.804G\>A(p.W268X) {#ajmgb32603-sec-0016}

The pathogenicity of this mutation was analyzed by MutationTaster software and SPIDEX (<http://tools.genes.toronto.edu/>), with the results suggesting "disease causing automatic" with a MutationTaster score of 1, and a SPIDEX score of −61.61 with the meaning of pathogenic possibility. An alignment of the amino acid sequence of nine species from UCSC Genome Browse suggested the evolutionary conservation of c.804G\>A. The variant of c.804G\>A (p.W268X) was predicted to be a disease‐causing mutation.

### 3.3.2. c.1127T\>C(p.L376P) {#ajmgb32603-sec-0017}

The pathogenicity of this mutation was analyzed by SIFT, Polyphen‐2, and MutationTaster software. The results suggested c.1127T\>C was "damaging" with a SIFT score of 1, "possibly damaging" with a Polyphen‐2 score of 0.999, and "disease causing" with a MutationTaster score of 1. An alignment of the amino acid sequence of nine species from UCSC Genome Browse suggested the evolutionary conservation of c.1127T\>C. The variant c.1127T\>C(p.L376P) was predicted to be a disease‐causing mutation.

### 3.3.3. c.1764‐4C\>A {#ajmgb32603-sec-0018}

The score of the splicing variants from SPIDEX was −10.47, which means low pathogenicity. This variant was predicted to be a polymorphism.

### 3.3.4. c.2073G\>A(p.K691K) {#ajmgb32603-sec-0019}

This variant causes no change in amino acid, and its SPIDEX score was −0.21, which means low pathogenicity. This variant was also predicted to be a polymorphism.

### 3.3.5. Haplotype of *TMC1* c.2050G {#ajmgb32603-sec-0020}

Four families (XJA, M126, M372, and XJ87) with *TMC1* c.2050G\>C mutations were haplotype analyzed with SNPs. A total of 53 SNPs was used to construct haplotypes for *TMC1* c.2050G\>C, and two generations of these families were tested. The proband of each family was divided into two haplotypes from parents. According to the results of SNP testing, the haplotype of *TMC1* c.2050G\>C was identical for the four families (Figure [3](#ajmgb32603-fig-0003){ref-type="fig"}).

![Haplotype of the four families. REF, reference sequence; ALT, alteration sequence; −1, haplotypes from the father; −2, haplotypes from the mother. \[Color figure can be viewed at <http://wileyonlinelibrary.com>\]](AJMG-177-301-g003){#ajmgb32603-fig-0003}

4. DISCUSSION {#ajmgb32603-sec-0021}
=============

Most reports about mutations of *TMC1* were from the special pedigree study of families with consanguineous marriages. Kalay reported *TMC1* mutations in 6% (4/65) of the *GJB2*‐negative ARNSHL families and 4% (4/93) of all ARNSHL families from the northeast and east of Turkey (Kalay et al., [2005](#ajmgb32603-bib-0006){ref-type="ref"}). *TMC1* mutations account for 3.4% (19/557) of recessive deafness in Pakistani ARNSHL families, 3.5% (3/85) in Tunisian families (Tlili et al., [2008](#ajmgb32603-bib-0012){ref-type="ref"}), and 1.6% in India (Ganapathy et al., [2014](#ajmgb32603-bib-0004){ref-type="ref"}). The novel mutations are all from families with consanguineous marriages. The hot spot in Pakistan was p.R34X (1.8%,10/557). Kitajiri et al. ([2007](#ajmgb32603-bib-0007){ref-type="ref"}) designed three short‐tandem repeats (STRs) and one SNP to test 10 families with p.R34X; the results strongly suggested a single ancestral origin of this mutation. In past years, there were few reports of hot spots; most reports were about novel mutations of *TMC1*, suggesting that *TMC1* is a highly conserved gene and its variants are rarely tolerated (Bademci et al., [2016](#ajmgb32603-bib-0002){ref-type="ref"}).

In China, recent studies on *TMC1* mutations such as c.589G\>A, c.1171C\>T (Xue et al., [2013](#ajmgb32603-bib-0014){ref-type="ref"}), c.1209G\>C (Tao et al., [2013](#ajmgb32603-bib-0011){ref-type="ref"}Tao, Xiaoming, Yongchuan, Lei, & Hao, [2013](#ajmgb32603-bib-0011){ref-type="ref"}), c.1253T\>A (Yali et al., [2014](#ajmgb32603-bib-0015){ref-type="ref"}), c.1714G\>A (Xue et al., [2015](#ajmgb32603-bib-0013){ref-type="ref"}), and c.1979C\>T (Jiongjiong et al., [2016](#ajmgb32603-bib-0005){ref-type="ref"}) have been reported. All mutations were analyzed by genetic testing of sporadic families without regional specificity. In this study, a high incidence of *TMC1* mutations in Xiamen was observed in the genetic testing of sporadic families and epidemiologic investigation in a deaf population revealing a hot spot phenomenon in this area.

South Fujian, including Xiamen with the dialect of Hokkien (Southern Min), showed special mutation sites in common deafness‐causing genes. The second most common mutation of *SLC26A4* was c.2168A\>G (p.H723R) in most areas of China, while it was c.1079C\>T (p.A360V) in the Xiamen patient cohort, which has rarely been reported in other areas of China (Yi et al., [2015](#ajmgb32603-bib-0016){ref-type="ref"}). A similar phenomenon was found in *TMC1* screening of the deaf population in the Xiamen area.

Ruling out the mutations that result in homozygous or compound heterozygotes in the normal hearing database (in‐house NGS database of our own lab), a homozygous *TMC1* c.2050G\>C was found through NGS in two deaf children in a XJA family with two heterozygous normal hearing parents. Because the proband of XJA was from Xiamen Special Education School in Fujian province, we analyzed the other 110 patients from this school who lacked positive pathogenic mutations of three common deafness genes (*GJB2*, *SLC26A4*, and *mtDNA 12SrRNA*). There were four compound heterozygotes of TMC1 c.2050G\>C, which means that the mutation allele frequency of *TMC1* was 1.9% (6/310) in this group. The detection rate of this mutation in 100 normal Xiamen people was zero. Two other families (M126, M372) with hearing‐impaired children and normal parents were found to have homozygous *TMC1* c.2050G\>C in the proband and heterozygous *TMC1* c.2050G\>C in the parents. These two families were also from South Fujian. The haplotype of *TMC1* c.2050G\>C shows the founder effect of the four families (XJA, M126, M372, and XJ87). Meanwhile, the haplotype of *TMC1* c.1396_1398delAAC was different from the one of *TMC1* c.2050G\>C. In China, close‐relative marriages are forbidden, so the high incidence of the same mutation, such as *TMC1* c.2050G\>C, in one area may be explained by its founder effect in very early ancestors.

In the investigation of the Xiamen Special Education School, four novel mutations of *TMC1* were found that were not identified by previous studies on *TMC1* mutations in China. Pathogenicity analysis of c.804G\>A (p.W268X) and c.1127T\>C (p.L376P) suggested possible damaging changes in the protein structure, and according to the structural prediction for these proteins of human wild‐type sequenced evolutionary conservation, we predicted the pathogenicity of these two novel mutations to be high. The *TMC1* mutation detection rate was 3.2% in Xiamen Special Education School, which means *TMC1* could be the fourth most common deafness gene in this area.

5. CONCLUSIONS {#ajmgb32603-sec-0022}
==============

In this study, special hotspots and spectra of *TMC1* mutations in the Xiamen deaf population were revealed. Haplotype analysis is useful to understand the founder effect of hot spot mutations, and this information will be helpful in designing the protocol for genetic testing for deafness and achieving an accurate molecular diagnosis in this area.
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